Literature DB >> 7488154

Drug-stimulated ATPase activity of a deletion mutant of the human multidrug-resistance protein (MDR1).

E Welker1, K Szabó, Z Holló, M Müller, B Sarkadi, A Váradi.   

Abstract

The baculovirus-insect cell system has been used for the functional expression of the human multidrug resistance protein (MDR1) and a mutant MDR1 variant lacking a twenty amino acid segment from the first extracellular loop (delta aa78-97 MDR1). Both MDR1 proteins were found to be correctly inserted into the insect cell membrane as indicated by their interaction with MRK 16 antibody. The removal of the 78-97 segment from the first extracellular loop dramatically altered drug-stimulated ATPase activity. Rhodamine 123 or vinblastine were not able to stimulate the mutant protein and Calcein AM had also little effect. In contrast, verapamil increased the ATPase activity of the mutant almost to the same maximal level as that of the wild type. However, the verapamil concentration needed for the half maximal stimulation of the ATPase activity was found to be about hundred times higher than that for the wild type MDR1. These results indicate that a partial deletion of an extracellular loop modulates the affinity of MDR1 for its transportable substrates in a variable fashion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488154     DOI: 10.1006/bbrc.1995.2665

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform.

Authors:  Jacqueline K Lekostaj; Linda E Amoah; Paul D Roepe
Journal:  Mol Biochem Parasitol       Date:  2007-10-05       Impact factor: 1.759

2.  Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.

Authors:  E Bakos; I Klein; E Welker; K Szabó; M Müller; B Sarkadi; A Váradi
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Morgan E Gibbs; Robert W Barnes; Arthur G Roberts
Journal:  Biochem Pharmacol       Date:  2016-08-13       Impact factor: 5.858

4.  Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.

Authors:  C Pascaud; M Garrigos; S Orlowski
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

5.  Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.

Authors:  Kaitlyn V Ledwitch; Robert W Barnes; Arthur G Roberts
Journal:  Biosci Rep       Date:  2016-01-28       Impact factor: 3.840

6.  Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein.

Authors:  Shahrooz Vahedi; Sabrina Lusvarghi; Kristen Pluchino; Yinon Shafrir; Stewart R Durell; Michael M Gottesman; Suresh V Ambudkar
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.